Wireless capsule endoscopy in diagnostics of enteropathy induced by nonsteroidal anti-inflammatory drugs

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004940

Enrollment

110

Registered

2013-05-02

Start date

2012-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NSAID induced enteropathy Normal small bowel findings

Interventions

Group 1: Wireless capsule endoscopy in patients with NSAID medication for rheumatoid arthritis Group 2: Wireless capsule endoscopy in patients with NSAID medication for osteoarthritis Group 3: Wire

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Rheumatoid arthritis or osteoarthritis patients and chronic NSAID medication (more than 1 month) or Healthy volunteers with no NSAID medication

Exclusion criteria

Exclusion criteria: Gastroesophageal reflux disease, swallowing disorders, gastroduodenal ulcer disease, small bowel disease, inflammatory bowel disease, small bowel stenosis and pregnancy. For the healthy volunteer – history of NSAIDs in the past year and pregnancy.

Design outcomes

Primary

Measure	Time frame
clinical, endoscopic, and laboratory characteristics of NSAID-induced enteropathy.	—

Countries

Czechia

Contacts

Public ContactIlja Tachecí

2nd Dpt of Internal Medicine - Gastroenterology, University hospital and Charles University - Medical faculty

tacheci@gmail.com00420777607574

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 22, 2026